Special Offers & Promotions



Latest News



View Channel

New Products



View Channel

Video Presentations



View Channel

Separation Science



View Channel

Microscopy & Image Analysis



View Channel

Laboratory Automation & IT Solutions



View Channel


Optibrium Expands US and UK Operations

publication date: Feb 21, 2018
author/source: Optibrium Ltd

optibriumOptibrium, a developer of software for small molecule drug discovery, today announced it has appointed Dr. Scott Lyon as Director of Business Development and relocated its Headquarters and R&D facilities, to Cambridge Innovation Park, Cambridge, UK.

Optibrium’s move to larger premises is driven by the company’s rapid recent growth and will accommodate future expansion plans as it accelerates its R&D pipeline and extends research into new technologies to improve the efficiency and productivity of the drug discovery process. In the last year Optibrium has grown by 60%, expanding its computational chemistry, software development and application science teams.

As part of this growth strategy, Dr. Scott Lyon joins Optibrium on the west coast of North America, where he has responsibility for supporting the company’s existing client base and for developing new business opportunities for StarDrop and the company’s range of products for small molecule design, optimisation and data analysis. Scott brings 20 years of experience in business development and support for scientific software and services, having previously worked at organisations including MDL, CambridgeSoft and Thomson Reuters. He has BSc from Carnegie Mellon University and a PhD in Chemistry from the University of Arizona.

Dr Matthew Segall, Optibrium’s CEO, commented: “As we move to larger, custom-designed offices, it is encouraging to see that our ongoing investment in the best scientists and engineers, who deliver cutting-edge features to our users, has resulted in strong revenue growth and thus sets the foundations for further expansion.  

“We are pleased to welcome Scott to the US team and look forward to him developing our west coast community, building on our success by providing local support to our clients and maintaining Optibrium’s reputation for excellence in customer service.”

Dr Scott Lyon added: “Optibrium’s unique drug discovery software and dedication to its clients offers a great opportunity to build for success. I am delighted to join the team and contribute to the company’s further development.

more news from optibrium

If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month



Today's Picks



Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners


Exhibitions & Events